Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13304-13312
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Table 3 Relationship between serum Spondin-2 expression and immune response in patients with cervical cancer (mean ± SD)
| Group | n | IL-2 (pg/mL) | TNF-ɑ (ng/mL) | IL-4 (pg/mL) | IL-5 (pg/mL) |
| High Spondin-2 group | 101 | 3.52 ± 0.83 | 10.62 ± 1.80 | 2.98 ± 0.53 | 4.43 ± 1.08 |
| Low Spondin-2 group | 46 | 4.12 ± 1.13 | 13.83 ± 2.56 | 2.45 ± 0.76 | 3.18 ± 0.72 |
| t value | - | 3.614 | 8.735 | 4.879 | 7.153 |
| P value | - | 0.000 | 0.000 | 0.000 | 0.000 |
- Citation: Zhang LL, Lin S, Zhang Y, Yao DM, Du X. Serum Spondin-2 expression, tumor invasion, and antitumor immune response in patients with cervical cancer. World J Clin Cases 2022; 10(36): 13304-13312
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13304.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13304